Showing 521 - 530 of 1364 results

Showing Results for: “diabetes”

Step Out Walk: Tennessee to Unite the Community in the Fight to End Diabetes

On Saturday, May 2, the American Diabetes Association ® (ADA) will host its signature fundraising event to raise awareness, connect communities, and strengthen critical support for individuals and families impacted by diabetes. Step Out ® Walk: Tennessee will bring together the diabetes community, volunteers, and Diabetes Advocates for a meaningful walk welcoming people of all ages and abilities. Time and date: May 2 from 7:30–11:30 a.m. Location: oneC1TY Nashville, 8 City Blvd., Nashville, TN 37203 Register, join or start a team, and fundraise: diabetes.org/StepOutTennessee Step Out Walk

Angela Bassett headlines Know Diabetes by Heart’s virtual show from the Apollo Theater

The American Heart Association ® and American Diabetes Association’s ® joint initiative takes to Harlem’s World-Famous stage for an evening of entertainment and health empowerment rooted in Black culture Golden Globe ®-winning and Academy Award®-nominated actress Angela Bassett will perform an original monologue based on her family’s personal experience with type 2 diabetes and heart disease during a free, virtual show she’s also hosting from Harlem’s World-Famous Apollo Theater on Tuesday, May 25, 2021. The event is produced and presented by Know Diabetes by Heart™, a joint initiative of the

Important Updates to the Standards of Medical Care in Diabetes—2022 Incorporate New Evidence

Today, the American Diabetes Association ® (ADA) published important updates to the Standards of Medical Care in Diabetes—2022 (Standards of Care), in annotations as the Living Standards of Care. Changes include new data on: Finerenone and its effects in people with type 2 diabetes and chronic kidney disease on cardiovascular outcome SGLT2 inhibitors and their effects in people with type 2 diabetes on heart failure and renal outcomes New information on calculating eGFR and inclusion of race for kidney disease diagnosis These amendments were driven by recently published research and were

ADA Statement Regarding Updated Data from The National Diabetes Statistics Report Provided by CDC

The American Diabetes Association ® (ADA) today released the following statement regarding the updated data from the National Diabetes Statistics Report provided by the Centers for Disease Control and Prevention (CDC) on the number of adults living in the U.S. with diabetes and prediabetes: "The new CDC data show an alarming increase of diabetes in our nation among adults, with 133 million Americans now living with diabetes or prediabetes, which is an increase of 11 million more Americans. Even more concerning, of those 133 million Americans, there are 96 million adults in the U.S. who

Current Youth and Young Adults with Diabetes Have Worse Glycemic Control Than Past Groups

Latest CDC and NIDDK sponsored SEARCH for Diabetes in Youth research indicates substantial percentage of today’s youth with diabetes are not meeting recommended A1C goals Despite the increased availability of diabetes technology, new therapies and more aggressive glycemic targets, today’s youth and young adults with diabetes in the United States are not demonstrating improved glycemic control compared to their counterparts from years past. Most notably, many age groups have worse glycemic control compared to youth and young adults from 2002-2007. Researchers revealed these data today at the

Frank J. Snoek, PhD, Receives American Diabetes Association’s® 2019 Richard R. Rubin Award

Frank J. Snoek, PhD, has been selected to receive the American Diabetes Association's® (ADA's) 2019 Richard R. Rubin Award. This award recognizes a behavioral researcher who has made outstanding, innovative contributions to the study and understanding of the behavioral aspects of diabetes in diverse populations. Dr. Snoek will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Richard R. Rubin Award Lecture titled, “ #DiabetesPsychologyMatters,” on Saturday, June 8. Currently, Dr

The American Diabetes Association Honors Dr. Rodriguez with Federal Advocate of the Year Award

The Federal Advocate of the Year Award from the American Diabetes Association ® (ADA) recognizes an individual whose leadership and dedication have significantly advanced federal diabetes advocacy and strengthened the voice of the diabetes community on Capitol Hill. The ADA is proud to announce Henry Rodriguez, MD, as the 2026 Federal Advocate of the Year for his outstanding commitment, leadership, and tireless advocacy on behalf of people living with diabetes across the United States. Dr. Rodriguez was honored during the ADA’s 2026 Call to Congress event in Washington, DC, where Diabetes

Peter Rossing, MD, DMSc, Receives the American Diabetes Association’s® 2019 Edwin Bierman Award

Peter Rossing, MD, DMSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Edwin Bierman Award. This award recognizes a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors. Dr. Rossing will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7–11, 2019, at the Moscone Convention Center in San Francisco. He will deliver his Edwin Bierman Award Lecture, titled “ Linking Kidney and Cardiovascular Complications—Impact on Prognosis and Treatment,” on

Delaware Governor Signs Law Capping Insulin Co-Pays at $100 for People with Diabetes

The American Diabetes Association® applauds Delaware’s governor and legislature for passing insulin co-pay cap and formulary provisions Recently, Delaware House Bill 263 was signed into law by Governor John Carney. A provision in the law limits cost sharing for insulin to $100 per 30-day supply for those with state-regulated commercial health insurance plans. The law also requires plans’ prescription drug formularies include at least one rapid, short, intermediate, and long-acting insulin on the formularies’ lowest tier. The new law, supported by the American Diabetes Association® (ADA), will

Statement from the American Diabetes Association on Nevada’s Action to Cap Insulin Costs

This week, Nevada became the 28 th state to approve legislation lowering out-of-pocket costs for insulin in state-regulated health insurance plans. In response to Governor Lombardo approving Assembly Bill 555, Christine Fallabel, the state government affairs director at the American Diabetes Association ® (ADA), issued the following statement: “The ADA applauds Nevada policymakers for the passage of AB 555, which limits cost-sharing for insulin to $35 for a 30-day supply for those on state-regulated commercial health insurance plans. Addressing insulin affordability will help Nevadans with